470 related articles for article (PubMed ID: 29626211)
1. Targeting cytokines to treat asthma and chronic obstructive pulmonary disease.
Barnes PJ
Nat Rev Immunol; 2018 Jul; 18(7):454-466. PubMed ID: 29626211
[TBL] [Abstract][Full Text] [Related]
2. Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease.
Ying S; O'Connor B; Ratoff J; Meng Q; Fang C; Cousins D; Zhang G; Gu S; Gao Z; Shamji B; Edwards MJ; Lee TH; Corrigan CJ
J Immunol; 2008 Aug; 181(4):2790-8. PubMed ID: 18684970
[TBL] [Abstract][Full Text] [Related]
3. Combined blockade of IL-25, IL-33 and TSLP mediates amplified inhibition of airway inflammation and remodelling in a murine model of asthma.
An G; Wang W; Zhang X; Huang Q; Li Q; Chen S; Du X; Corrigan CJ; Huang K; Wang W; Chen Y; Ying S
Respirology; 2020 Jun; 25(6):603-612. PubMed ID: 31610614
[TBL] [Abstract][Full Text] [Related]
4. Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD.
Calderon AA; Dimond C; Choy DF; Pappu R; Grimbaldeston MA; Mohan D; Chung KF
Eur Respir Rev; 2023 Mar; 32(167):. PubMed ID: 36697211
[TBL] [Abstract][Full Text] [Related]
5. Thymic stromal lymphopoietin receptor blockade reduces allergic inflammation in a cynomolgus monkey model of asthma.
Cheng DT; Ma C; Niewoehner J; Dahl M; Tsai A; Zhang J; Gonsiorek W; Apparsundaram S; Pashine A; Ravindran P; Jung J; Hang J; Allard J; Bitter H; Tribouley C; Narula S; Wilson S; Fuentes ME
J Allergy Clin Immunol; 2013 Aug; 132(2):455-62. PubMed ID: 23810153
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes.
Barnes PJ
J Allergy Clin Immunol; 2015 Sep; 136(3):531-45. PubMed ID: 26343937
[TBL] [Abstract][Full Text] [Related]
7. Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation.
Kabata H; Moro K; Fukunaga K; Suzuki Y; Miyata J; Masaki K; Betsuyaku T; Koyasu S; Asano K
Nat Commun; 2013; 4():2675. PubMed ID: 24157859
[TBL] [Abstract][Full Text] [Related]
8. Function and mechanisms of TSLP/TSLPR complex in asthma and COPD.
Redhu NS; Gounni AS
Clin Exp Allergy; 2012 Jul; 42(7):994-1005. PubMed ID: 22168549
[TBL] [Abstract][Full Text] [Related]
9. Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: The role of thymic stromal lymphopoietin.
Liu S; Verma M; Michalec L; Liu W; Sripada A; Rollins D; Good J; Ito Y; Chu H; Gorska MM; Martin RJ; Alam R
J Allergy Clin Immunol; 2018 Jan; 141(1):257-268.e6. PubMed ID: 28433687
[TBL] [Abstract][Full Text] [Related]
10. Cytokine-directed therapies for the treatment of chronic airway diseases.
Barnes PJ
Cytokine Growth Factor Rev; 2003 Dec; 14(6):511-22. PubMed ID: 14563353
[TBL] [Abstract][Full Text] [Related]
11. The role of thymic stromal lymphopoietin in allergic inflammation and chronic obstructive pulmonary disease.
Fang C; Siew LQ; Corrigan CJ; Ying S
Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):81-90. PubMed ID: 20143171
[TBL] [Abstract][Full Text] [Related]
12. Targeting Cytokines as Evolving Treatment Strategies in Chronic Inflammatory Airway Diseases.
Garth J; Barnes JW; Krick S
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380761
[TBL] [Abstract][Full Text] [Related]
13. Thymic stromal lymphopoietin plays divergent roles in murine models of atopic and nonatopic airway inflammation.
Yadava K; Massacand J; Mosconi I; Nicod LP; Harris NL; Marsland BJ
Allergy; 2014 Oct; 69(10):1333-42. PubMed ID: 24961817
[TBL] [Abstract][Full Text] [Related]
14. The Therapeutic Potential for Targeting Group 2 Innate Lymphoid Cells in Asthma.
Matsuyama T; Matsuyama H; Dotake Y; Takagi K; Machida K; Inoue H
Front Immunol; 2022; 13():930862. PubMed ID: 35911708
[TBL] [Abstract][Full Text] [Related]
15. Elevated Expression of IL-33 and TSLP in the Airways of Human Asthmatics In Vivo: A Potential Biomarker of Severe Refractory Disease.
Li Y; Wang W; Lv Z; Li Y; Chen Y; Huang K; Corrigan CJ; Ying S
J Immunol; 2018 Apr; 200(7):2253-2262. PubMed ID: 29453280
[TBL] [Abstract][Full Text] [Related]
16. Constitutive and inducible thymic stromal lymphopoietin expression in human airway smooth muscle cells: role in chronic obstructive pulmonary disease.
Zhang K; Shan L; Rahman MS; Unruh H; Halayko AJ; Gounni AS
Am J Physiol Lung Cell Mol Physiol; 2007 Aug; 293(2):L375-82. PubMed ID: 17513456
[TBL] [Abstract][Full Text] [Related]
17. Cytokine inhibition in the treatment of COPD.
Caramori G; Adcock IM; Di Stefano A; Chung KF
Int J Chron Obstruct Pulmon Dis; 2014; 9():397-412. PubMed ID: 24812504
[TBL] [Abstract][Full Text] [Related]
18. Thymic stromal lymphopoietin: a promising therapeutic target for allergic diseases.
Wang WL; Li HY; Zhang MS; Gao PS; He SH; Zheng T; Zhu Z; Zhou LF
Int Arch Allergy Immunol; 2013; 160(1):18-26. PubMed ID: 22948028
[TBL] [Abstract][Full Text] [Related]
19. Thymic stromal lymphopoietin: a central regulator of allergic asthma.
Watson B; Gauvreau GM
Expert Opin Ther Targets; 2014 Jul; 18(7):771-85. PubMed ID: 24930783
[TBL] [Abstract][Full Text] [Related]
20. Expression and Regulation of Thymic Stromal Lymphopoietin and Thymic Stromal Lymphopoietin Receptor Heterocomplex in the Innate-Adaptive Immunity of Pediatric Asthma.
Lin SC; Cheng FY; Liu JJ; Ye YL
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
